Marco Brugia

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026.

The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026.

Journal: Journal of hematology & oncology

Published: June 04, 2026

Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: results from the MAVERIC phase II trial.

Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: results from the MAVERIC phase II trial.

Journal: The oncologist

Published: October 07, 2025

Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift.

Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift.

Journal: World journal of gastrointestinal oncology

Published: March 05, 2025

Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS.

Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS.

Journal: Critical reviews in oncology/hematology

Published: October 26, 2024

Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma.

Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma.

Journal: Anti-cancer drugs

Published: August 09, 2024

Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.

Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.

Journal: Future oncology (London, England)

Published: December 05, 2023

Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.

Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.

Journal: Cancers

Published: March 30, 2023

Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer.

Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer.

Journal: International journal of molecular sciences

Published: February 18, 2023

Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer.

Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer.

Journal: Anti-cancer drugs

Published: February 02, 2023

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.

Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.

Journal: International journal of molecular sciences

Published: January 26, 2023

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer.

Journal: Frontiers in oncology

Published: September 27, 2022

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 06, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026